Zenas Biopharma - Multiplikator nilai perusahaan marang pendapatan ZBIO

Zenas Bio (ZBIO) - logo korporat

The optimization of cross-border supply chains for immunological agents supports the high margins of Zenas Biopharma Inc (ZBIO). The EV-to-revenue ratio confirms this trend, with the latest reading standing at 137539.09. Demand for inflammation therapies remains independent of economic cycles, while expanding the workforce by attracting leading researchers through stock option programs ensures sustainable growth of the company's potential.

ZBIO: Multiplikator EV/Sales Zenas Biopharma, Inc. 23.11.2025 - 20.11.2026

Rincian metrik keuangan lan pasar Zenas Biopharma, Inc. (ZBIO)

- indikator dhuwit lan arus kas:
Pambiji fundamental perusahaan:Zenas Biopharma Inc - ZBIO
Produk asli Zenas Bio

This indicator reflects the ratio of total enterprise value to operating income, excluding the impact of debt load. For Zenas Biopharma Inc (ZBIO), this metric assesses market expectations for the commercialization of patent-protected bispecific antibodies. By analyzing the trend of the company's value-to-revenue ratio, an investor can identify if the asset is overbought. A sharp spike in the line signals a speculative bubble, while a stable figure confirms the fundamental value of the innovative developments.

Analisis pesaing Zenas Biopharma Inc

ARGX - Multiplikator EV/Sales|BNTX: Multiplikator EV/Sales|ABVX (Abivax SA) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ADMA Corp|Multiplikator nilai perusahaan marang pendapatan Protagonist Therapeutics PTGX|Nilai perusahaan marang pendapatan IMVT (Immunovant Therapeutics)|Rasio total nilai perusahaan marang pendapatan kiniksa.com|Rasio nilai perusahaan marang pendapatan Grifols Biemat GRFS|Koefisien nilai perusahaan marang pendapatan ADPT (Adaptive Biotechnologies Corporation)|celldex.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Aurinia Pharma AUPH|biocryst.com (BCRX) - Rasio nilai perusahaan marang pendapatan|Vera Therapeutics, Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Dianthus Therapeutics Inc|Pharvaris NV (PHVS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales ABCL|Tourmaline Corp - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales PGEN (precigen.com)|Rasio nilai perusahaan marang dodolan pharming.com|NKTR - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Upstream Bio Corp|IMNM: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Gossamer Bio, Inc. (GOSS)|Rasio nilai perusahaan marang pendapatan KalVista Pharmaceuticals|Septerna Inc (SEPN) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales PVLA|SVRA (Savara) - Nilai bisnis marang pendapatan|Rigel Pharma - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan AnaptysBio Corp (ANAB)|ATXS: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ENGN (enGene Holdings Inc.)|RAPT Therapeutics Inc. (RAPT) - Rasio nilai perusahaan marang pendapatan|Aerovate Therapeutics Inc (JBIO) - Multiplikator EV/Sales|ACRS (Aclaris Therapeutics, Inc) - Multiplikator EV/Sales|Kyverna (KYTX) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales TLSA|Nilai perusahaan marang pendapatan Cabaletta Bio, Inc. CABA|Ventyx Biosciences - Nilai perusahaan marang pendapatan|THTX: Rasio nilai perusahaan marang pendapatan|AVTX - Rasio nilai perusahaan marang pendapatan|ELDN: Rasio nilai perusahaan marang pendapatan|Agenus Inc. (AGEN) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Climb Bio Inc|ZURA (Zura Bio Ltd) - Multiplikator EV/Sales|Multiplikator EV/Sales aTyr Pharma Inc|Multiplikator EV/Sales ADAG|Rasio total nilai perusahaan marang pendapatan ImageneBio|Multiplikator EV/Sales STTK (Shattuck Labs Inc)|Multiplikator EV/Sales Equillium, Inc. EQ|CNTB - Rasio nilai perusahaan marang pendapatan|Immunic Therapeutics (IMUX) - Nilai perusahaan marang pendapatan|ATRA: Multiplikator EV/Sales|InflaRx GmbH (IFRX) - Multiplikator EV/Sales|XFOR (x4pharma.com) - Multiplikator EV/Sales|Multiplikator EV/Sales Adicet Bio|Rasio nilai perusahaan marang pendapatan Celularity Inc (CELU)|Nilai perusahaan marang pendapatan INmune Bio Corp INMB|Rasio nilai perusahaan marang pendapatan Barinthus Biotherapeutics plc BRNS|KZR - Nilai perusahaan marang pendapatan|sabbiotherapeutics.com - Multiplikator EV/Sales|akaritx.com (AKTX) - Nilai perusahaan marang pendapatan|ENLV: Multiplikator EV/Sales|QTTB (Q32 Bio Inc) - Rasio nilai perusahaan marang pendapatan|GOVX (geovax.com) - Multiplikator EV/Sales|Multiplikator EV/Sales Edesa Biotech Corp|Multiplikator EV/Sales IBIO|Nilai perusahaan marang pendapatan Carisma Tx CARM|Rasio nilai perusahaan marang pendapatan XTL Biopharmaceuticals Ltd XTLB|Multiplikator EV/Sales Bolt Biotherapeutics BOLT|HCW Biologics - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan aptevotherapeutics.com|AIM (AIM ImmunoTech, Inc.) - Nilai perusahaan marang pendapatan|Aditxt Corp - Nilai bisnis marang pendapatan|GRI (GRI Bio Inc) - Multiplikator EV/Sales|Multiplikator EV/Sales XORTX Therapeutics Inc|Rasio nilai perusahaan marang pendapatan Vyome Therapeutics (HIND)|REVB - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Indaptus Therapeutics, Inc. INDP|Multiplikator EV/Sales scinai.com SCNI|CalciMedica Inc - Multiplikator EV/Sales|AFMD - Multiplikator EV/Sales|ALLK: Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan HOOK (HOOKIPA Pharma, Inc.)|IGMS (IGM Biosciences) - Multiplikator EV/Sales|ITOS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan OCEA (Ocean Biomedical)|TCBP: Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Third Harmonic Bio Inc THRD